IVF twins 'sicker in early life'
By BBC,
BBC News
| 05. 20. 2009
A study found these babies were far more likely to be admitted to neonatal intensive care and to be hospitalised in their first three years of life.
Other work in the same journal, Human Reproduction, provides reassurance on the outcomes of children born after embryos are frozen and stored, however.
A quarter of fertility treatment babies are now born after freezing.
Evidence from 21 controlled studies showed embryos that had been frozen shortly after they started to divide had a better, or at least as good, outcome in terms of premature birth and birth weight as children born from fresh cycles of IVF or another common assisted reproductive technique called ICSI (intracytoplasmic sperm injection).
The same cannot be said for twins born after assisted reproductive therapy (ART) when compared with naturally conceived twins.
It is known already that ART twins are at higher risk of problems such as low birth weight and premature delivery than singletons around the time of their birth, but, to a large extent, these risks exist as part of the problems associated with multiple births in...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...